Even when it is localised and resectable, cancer of the pancreas is almost always lethal. This German trial of post-operative gemcitabine has been going on since 1998 and has proved that this type of chemotherapy prolongs disease-free survival by a worthwhile amount, though in the final analysis patients given the treatment survived a median 22 […]
JAMA 17 Jan 2007
